StemCell Therapy

Santa Clara, CAMore Elmiron lawsuits are being filed in the U.S. and Canada has filed two class action lawsuits, all alleging the interstitial cystitis drug can cause permanent vision damage.

While plaintiffs complaints differ regarding how long Elmiron was used to treat interstitial cystitis, and a range of vision problems have been cited, all lawsuits, including the class action in British Columbia and the other in Quebec, are similar. All claim the manufacturers failed to disclose the serious link between Elmiron use and significant visual damage, including pigmentary maculopathy and Elmiron did not properly warn patients of the risks, according to the Quebec complaint.

In August 2020, two women in the U.S. filed lawsuits against Elmiron manufacturers Johnson & Johnson and its subsidiary Janssen, Bayer and Tevaaccusing them of failure to warn consumers of Elmirons risk, negligence, designing Elmiron in a way that makes the drug defective and hazardous to health, and fraudulent misrepresentation of the risks associated with Elmiron. One woman had taken Elmiron for about four years, the other woman ten years. These complaints (cases are Johns v. Alza Corp. et al., case number 3:20-cv-10341, and Levy v. Alza Corp., case number 3:20-cv-10342, both in the U.S. District Court for the District of New Jersey).

The British Columbia plaintiff, Arenlea Felker, filed the Elmiron side effects class action lawsuit against Janssen Inc. and Teva Branded Pharmaceutical Products R&D Inc. Felker, prescribed Elmiron to treat interstitial cystitis in 2005 and continued to take the medication daily, allegesthat the drug caused permanent vision-threatening eye disease called pigmentary maculopathy.

In a study published in Opthalmology back in November 2018, researchers concluded that maculopathy associated with chronic exposure to PPS is possibly avoidable". Another study published in January 2019 associated the Chronic use of pentosan polysulfate sodium with risk of vision-threatening disease, and a number of articles have been published with similar conclusions.

As well, studies have found that patients with interstitial cystitis who don't use Elmiron have no instances of pigmentary maculopathy. But many other issues are related to vision loss, from mental health issues to a higher risk of falling. One 2014 studypublished in JAMA Ophthalmologylinked poor vision to a reduced life expectancy. Additional issues can include cognitive decline, difficulty learning, and a feeling of being discriminated against.

See the rest here:
More Elmiron Lawsuits, including Canada Class Actions, and the Impact of Vision Loss - LawyersandSettlements.com

This entry was posted on September 30, 2020 at 4:48 pm and is filed under Opthalmology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |